Home/OpGen/Oliver Schacht, PhD
OS

Oliver Schacht, PhD

President, CEO & Director

OpGen

OpGen Pipeline

DrugIndicationPhase
Acuitas AMR Gene PanelAntibiotic resistance gene detection (isolates)Commercial
Acuitas AMR Gene Panel (ucp)Urinary Tract Infection (UTI) pathogen & resistance detectionDevelopment/Regulatory
Unyvero A50 RQ LRTILower Respiratory Tract InfectionsCommercial
Unyvero A50 RQ IAIIntra-Abdominal InfectionsCommercial
Unyvero A50 RQ BJIBone and Joint InfectionsCommercial
Unyvero A50 RQ BCUTesting from positive blood culturesCommercial